Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“Physicians will start reviewing AI-generated prescriptions only after they are prescribed for up to 500 patients.”
DisputedConfidence: LOW

Reasoning

The Nolla Health blog outlines a two‑stage pilot: in stage one (first 100 patients) two licensed physicians independently review and approve every AI‑generated prescription before it reaches the patient. Stage two mentions issuing prescriptions for up to 500 patients, but does not indicate that physician review begins only after reaching that number. The Verge article similarly notes physician oversight for complex cases. Therefore, the claim that physicians will start reviewing only after prescriptions have been issued to up to 500 patients is contradicted by the available evidence.

On confidence: Multiple primary sources directly describe the review process, showing physicians review prescriptions from the start, not only after 500 patients.

Important context

The claim concerns the timing of physician review in Nolla Health's AI prescription pilot. Evidence shows physician review occurs from the outset (first 100 patients), not after 500 patients.

Evidence

Supporting (2)

  • Tier 1 — Primary source
    This startup is issuing AI-generated acne prescriptions | The Verge

    dermatologists to focus on complex, high-risk patients.” The program will cost $4.99 / month, and only applies to Utah residents who are 18 years of age or older and have mild-to-moderate acne. Nolla Health says it will direct users to a…

  • Tier 1 — Primary source
    Nolla Health Launches the Nation's First AI-Powered Prescriptions

    residents can download the Nolla Derm app and opt in at a discounted $4.99/month. Each patient verifies their identity, goes through informed consent, a short intake questionnaire, and a quick five-angle face scan. In about 10–15 minutes,…

Limitations

The excerpts provided do not contain the full text of the sources; however, the key details about the review process are present. No additional independent sources were consulted. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Oct 5, 2026, 3:42 PM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

This startup is issuing AI-generated acne prescriptions

The Verge · Emma Roth